These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21062241)

  • 1. Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives.
    Cecco S; Muraro E; Giacomin E; Martorelli D; Lazzarini R; Baldo P; Dolcetti R
    Curr Cancer Drug Targets; 2011 Jan; 11(1):85-102. PubMed ID: 21062241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer vaccines entering Phase III clinical trials.
    Durrant LG; Spendlove I
    Expert Opin Emerg Drugs; 2003 Nov; 8(2):489-500. PubMed ID: 14662001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines: on the threshold of success.
    Emens LA
    Expert Opin Emerg Drugs; 2008 Jun; 13(2):295-308. PubMed ID: 18537522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer vaccines: Where are we going?
    Cebon J
    Asia Pac J Clin Oncol; 2010 Mar; 6 Suppl 1():S9-15. PubMed ID: 20482531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer vaccines: what do we need to measure in clinical trials?
    Kudrin A
    Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer vaccines: translation from mice to human clinical trials.
    Maeng H; Terabe M; Berzofsky JA
    Curr Opin Immunol; 2018 Apr; 51():111-122. PubMed ID: 29554495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
    Seremet T; Brasseur F; Coulie PG
    Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
    Lévy F; Colombetti S
    Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic cancer vaccines based on molecularly defined human tumor antigens.
    Romero P; Pittet M; Dutoit V; Zippelius A; Liénard D; Lejeune F; Guillaume P; Rimoldi D; Valmori D; Speiser DE; Cerottini JC
    Vaccine; 2002 Dec; 20 Suppl 4():A2-7. PubMed ID: 12477422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer vaccines.
    Butterfield LH
    BMJ; 2015 Apr; 350():h988. PubMed ID: 25904595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer vaccines: can they improve survival?
    Dillman RO
    Cancer Biother Radiopharm; 2015 May; 30(4):147-51. PubMed ID: 25747158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guest editorial: Cancer immunology.
    Yasukawa M
    Int J Hematol; 2011 Mar; 93(3):261-262. PubMed ID: 21347643
    [No Abstract]   [Full Text] [Related]  

  • 14. Unique human tumor antigens: immunobiology and use in clinical trials.
    Parmiani G; De Filippo A; Novellino L; Castelli C
    J Immunol; 2007 Feb; 178(4):1975-9. PubMed ID: 17277099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor vaccination using monoclonal antibodies].
    Veelken H
    Internist (Berl); 2001 Jun; 42(6):874-83. PubMed ID: 11449634
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent developments in therapeutic cancer vaccines.
    Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
    Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state and perspectives of dendritic cell vaccination in cancer immunotherapy.
    Farkas A; Conrad C; Tonel G; Borbenyi Z; Kemeny L; Dobozy A; Nestle FO
    Skin Pharmacol Physiol; 2006; 19(3):124-31. PubMed ID: 16612139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New cancer vaccine approaches.
    Kaplan JM
    Drugs Today (Barc); 2004 Nov; 40(11):913-29. PubMed ID: 15645004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to therapeutic cancer vaccines.
    Hellstrom KE; Hellstrom I
    Expert Rev Vaccines; 2003 Aug; 2(4):517-32. PubMed ID: 14711336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.